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CASE REPORT 
MYXOID LIPOSARCOMA ORIGINATING IN THE ANTERIOR 
MEDIASTINUM 
Mohammad Harisullah Khan, Ramsha Kashif, Hamza Abdur Rahim Khan, Saulat 
Hasnain Fatimi 
Department of Cardiothoracic Surgery, Aga Khan University, Karachi-Pakistan 
Myxoid liposarcomas of the head and neck are mostly metastatic in nature, with the primary 
lesion usually in lower extremities or retroperitoneum. Primary mediastinal liposarcomas are 
even rarer. Although there have been previous cases reporting their incidence, there is no 
evidence of any case comprising of both the neck and the mediastinal region yet. We here 
present a case of a 43 year old male with a primary liposarcoma of the myxoid subtype 
originating in the anterior mediastinum. This is the first time such a case has presented in 
literature. The patient presented with a right sided neck swelling associated with pain and 
shortness of breath upon lying down. CT neck revealed an enhancing mass extending from 
right cervical region to axilla and encasing the subclavian artery and involving a portion of 
the right lung. The patient underwent wide local excision of the mass along with 
chemoradiotherapy to prevent recurrence. 
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INTRODUCTION 
Myxoid liposarcoma is a subtype of liposarcoma 
which is categorized under soft tissue sarcomas. 
Soft tissue sarcomas (STSs) are malignant 
neoplasms originating from non-epithelial sources. 
They are mesenchymal tumours which are very 
common in adults. Their occurrence in the head 
and neck region however, is rare making up only 
1% of all head and neck cancers. With an annual 
incidence of 2.5 cases per million population , 
liposarcomas are the second most common type of 
soft tissue sarcomas (14%) with malignant fibrous 
histiocytoma (24%) being the most common soft 
tissue sarcoma.1,2 Majority of the liposarcomas in 
adults are detected more commonly in the lower 
extremities (43%), in particular the buttocks and 
the thighs, and at other instances, the 
retroperitoneum.3 Histopathologically speaking, 
liposarcomas are further divided into five 
subtypes: well-differentiated, dedifferentiated, 
round cell, myxoid and pleomorphic types.4  
Little work has been done on addressing 
the head and neck liposarcomas. The few case 
reports that have been published have only 
discussed a small number of patients since this 
tumour makes up only approx 4% of liposarcoma 
cases.5 Also, majority of the cases involving the 
neck and the mediastinum liposarcomas have 
reported it to be secondary in relation to metastasis 
from another primary commonly located in the 
extremities. In this case report, we present a very 
rare case of primary myxoidliposarcoma 
discovered in the neck region with mediastinal 
invasion and encompassment of the subclavian 
artery in a 43 year old gentleman. There has not 
been any report or evidence of a primary 
myxoidliposarcomas comprising both the neck and 
the mediastinal region previously. We have 
extensively reviewed the literature on pub med and 
Google scholar and no cases of primary myxoid 
liposarcomas involving the neck and mediastinum 
could be found. This case report also reviews the 
relevant literature related to this presentation. 
CASE REPORT 
A 43 years old gentleman, known case of 
hypertension for last 2 years, reported with 
complaint of a painful right sided neck mass since 
1 ½ years. The mass was associated with a 3 month 
history of progressive pain which was pressing in 
character and this was the reason for his visit to the 
clinic. Pain had become constant in nature since 7–
10 days. There was also history of shortness of 
breath on lying down since the past 2 months. No 
history of fever, dyspepsia or change in voice. His 
sleep, energy, appetite, and mood were unaffected 
since the onset of the disease. 
Local examination of the neck revealed 
right sided neck swelling in Level III-V extending 
below clavicle inferiorly and laterally, measuring 
around 4×10 cm, rounded, firm, non-tender, not 
attached to overlying skin with no other palpable 
neck nodes. ENT examination was within normal 
limits. 
Ultrasound of the neck region done 
previously showed a neck mass on the right side 
with Supraclavicular part measuring 4.7×2.2 cm 
and Infraclavicular part measuring 4.3×2.0 cm 
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respectively. FNAC also carried out previously 
revealed spindle cells with a myxoid background 
indicative of myxoid liposarcoma. 
Patient was advised MRI but he got CT scan 
done which showed an enhancing mass measuring 
4.8×12.6 cm. The mass exhibited slight 
heterogeneity, which is characteristic of the myxoid 
subtype and extended from Right cervical to below 
supraclavicular region and axilla (Figure-1). A small 
projection was found in Right lung apex but there 
was no rib erosion. The mass was partly encasing 
(abutting) the right subclavian artery and fully 
encasing subclavian vein (Figure-2). 
A tumour board meeting was called to 
discuss the case. Tumour board review is a 
treatment planning approach in which a number of 
doctors who are experts in different medical 
specialties review and discuss the medical 
condition and treatment options of a patient. 
Tumour board planned for wide local excision of 
the right neck and thoracic mass, along with 
thoracotomy for surgical resection of the involved 
potion of the lung to be performed by the 
Cardiothoracic Surgeon. An ENT surgery team 
was also involved as the tumour was enclosing the 
subclavian artery. 
In the current case, the patient underwent 
an extensive surgery which involved the ENT and 
the cardiothoracic surgery teams working together 
since the tumour had a very invasive spread and 
was enclosing the subclavian artery. The tumour 
was completely excised and chest drains were 
placed. The affected portion of the right lung was 
resected. Intraoperative findings included a 
lobulated mass arising from the supraclavicular 
fossa extending into the Infra-clavicular space, 
abutting the subclavian vessels and right chest wall 
but not invading it or entering into right pleural 
cavity. Histopathology report showed features of 
myxoidliposarcoma with some component of 
round cell 5% Grade 2. The patient was 
recommended to undergo radiotherapy (at 
radiation dose 60Gy) upon discharge with the aim 
of strengthening the effect of the treatment and 
reducing the risk of recurrence. 
Postoperatively, diet was started, patient 
mobilized and analgesic control provided. Chest 
drains were kept on suction and later removed. Chest 
physiotherapy was carried out with incentive 
spirometry.  
The patient was discharged oral pain killers 
and antibiotics. Chemotherapy 25 cycles with 
Lipozoid has been planned Post-operatively, the 
patient has been healthy for 10 months. Follow-up 
surveillance will continue. 
 
Figure-1: Computed Tomography scan of the chest 
with contrast showing the lesion (axial section) 
 
Figure-2: Computed Tomography scan of the chest 
with contrast showing the lesion (coronal section) 
DISCUSSION 
Liposarcomas arise from the deep situated adipose 
tissues of the body and have the characteristics of 
malignant mesenchymal neoplasms. Russell et al6 has 
found in a review of soft tissue sarcomas that only 
221 out of the 1215 sarcoma cases were reported to 
be liposarcomas. More importantly, only 10 (4%) out 
of those 221 were found to be located in the head and 
neck region. Primary liposarcomas in the 
mediastinum are very rare. In a study conducted by 
Hahn and Fletcher, it is seen that there are only 24 
cases of mediastinal liposarcoma over the course of 
13 years (1992–2005). Amongst those 24, only 9 
were found to be originating in the anterior 
mediastinum and of those, only 2 were of the myxoid 
subtype.7 
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As already mentioned, liposarcomas are 
classified in further five subtypes. These subtypes 
basically help in correlating the clinical picture of the 
disease with its prognosis and also in deciding the 
treatment options. The most common subtype 
amongst these is the myxoid, found to be present in 
almost 45–55% of the cases. Myxoid tumours are 
generally of low or intermediate grade, and are seen 
to have a decent prognosis. Its high grade counterpart 
is said to be the round cell subtype which represents 
about 15% of the total number of liposarcoma cases. 
The rest comprise of well-differentiated subtype with 
the lowest grade and the best prognosis, and the 
pleomorphic subtype with the highest grade and the 
worst prognosis. Also, the pleomorphic and the round 
cell types have been seen to have a higher rate of 
local recurrence and also, a higher risk of distant 
metastasis. According to the histopathology reports, 
our patient had myxiod subtype of liposarcoma with 
some component of round cell. 
These neoplasms are believed to be a result 
of a number of chromosomal abnormalities. The 
pathogenesis behind the myxoid subtype is 
translocation, with the most common being the t 
(12;16) (q13;p11.2) translocation. This involves the 
fusion of CHOP gene present on the chromosome 
and is normally responsible for regulating the process 
of adipocyte differentiation with the TLS gene 
present on chromosome 16.8,9 
Liposarcomas in the neck are usually 
misdiagnosed since they mostly have an 
asymptomatic course and appear very similar to a 
number of more commonly encountered benign 
lesions such as lipomas on gross inspection.1,9,10 
Hence, multiple imaging is required with MRI being 
the best option. In our scan, an MRI was advised but 
the patient went for a CT scan which exhibited slight 
heterogeneity, which is characteristic of the myxoid 
subtype. The gold standard for the diagnosis is 
however the biopsy. In our patient, a fine needle 
aspiration biopsy was performed which confirmed 
the diagnosis of the myxoidliposarcoma of a low 
grade with multiple number of lipoblasts present. 
Low grade myxoid tumors usually have an 
abundance of spindle-shaped cells and are considered 
to be of the least cellular form.11–13 
Once identified, the recommended treatment 
options include surgery with wide local excision 
performed and a consideration to undergo 
radiotherapy following the operation. Postoperative 
radiotherapy is considered to be the standard 
approach for nearly all intermediate or high-grade 
soft tissue sarcomas and the recommended 
postoperative radiation dose is 60–66 Gy in 1.8–2 Gy 
fractions. Local recurrence can develop in 
approximately 13% of the patients. According to a 
study done on the outcome of conservative surgery 
and radiation therapy in patients with liposarcoma, 
the 5 year, 10year, and 15-year survival rates were 
79%, 69%, and 61%, respectively.14 
REFERENCES 
1. Srivastava A, Ghosh A, Saha S, Saha VP, Chakraborty D. 
Sarcomas of head and neck - A 10 yrs experience. Indian J 
Otolaryngol Head Neck Surg 2007;59(4):322–6. 
2. Barile A, Zugaro L, Catalucci A, Caulo M, Di Cesare E, 
Splendiani A, et al. Soft tissue liposarcoma: histological 
subtypes, MRI and CT findings. Radiol Med 
2002;104(3):140–9. 
3. Spittle MF, Newton KA, Mackenzie DH. Liposarcoma. A 
review of 60 cases. Br J Cancer 1970;24(4):696–704. 
4. McMains CK, Gourin CG. Pathology: Sarcomas of the Head 
and Neck. 2009. [Internet]. [Cited 2016 Feb 28]. Available 
from: http://emedicine.medscape.com/article/871284-
overview#a4 
5. Schwartz RA, Centurion SA. Liposarcoma: Drugs and 
Diseases. [Internet] 2016 [cited 2016 Feb 28]. Available 
from: http://emedicine.medscape.com/article/1102007-
overview#a6. 
6. Russell WO, Cohen J, Enzinger F, Hajdu SI, Heise H, Martin 
RG, et al. A clinical and pathological staging system for soft 
tissue sarcomas. Cancer 1977;40(4):1562–70. 
7. Hahn HP, Fletcher CD. Primary mediastinal liposarcoma: 
clinicopathologic analysis of 24 cases. Am J Surg Pathol 
2007;31(12):1868–74. 
8. Dei Tos AP. Liposarcoma: new entities and evolving 
concepts. Ann Diagn Pathol 2000;4(4):252–66. 
9. Reitan JB, Kaalhus O, Brennhovd IO, Sager EM, Stenwig 
AE, Talle K. Prognostic factors in liposarcoma. Cancer 
1985;55(10):2482–90. 
10. Fletcher CDM, Unni KK, Mertens F, editors. World Health 
Organization classification of tumors. Pathology and genetics 
of tumours of soft tissue and bone. IARC Press; Lyon 2002.  
11. Ruacan S, Onerci M, Gedikoglu G, Dal T. Liposarcoma of the 
cheek: report of a case. J Oral Pathol Med 1993;22(1):46–7. 
12. Eeles RA, Fisher C, A'Hern RP, Robinson M, Rhys-Evans P, 
Henk JM, et al. Head and neck sarcomas: prognostic factors and 
implications for treatment. Br J Cancer 1993;68(1):201–7. 
13. Freedman AM, Reiman HM, Woods JE. Soft tissue sarcomas 
of the head and neck. Am J Surg 1989(158):367–72. 
14. Zagars GK, Goswitz MS, Pollack A, Liposarcoma: outcome 
and prognostic factors following conservation surgery and 
radiation therapy. Int J Radiat Oncol Biol Phys 
1996;36(2):311–9. 
 
Received: 7 May, 2016 Revised: 2 October, 2016 Accepted:10 October, 2016 
Address for Correspondence:  
Mohammad Harisullah Khan, Medical Student, Aga Khan University, Karachi-Pakistan 
Cell: +92 331 242 2898 
Email: harisukhan@gmail.com> 
 
